诺瓦瓦克斯医药持续推进与Sanofi合作,完成Nuvaxovid®欧盟市场授权转移并获得2500万美元里程碑付款

美股速递
Oct 07

诺瓦瓦克斯医药持续推进与Sanofi的合作伙伴关系,成功完成Nuvaxovid®在欧盟的市场授权转移,并因此获得2500万美元的里程碑付款。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10